[go: up one dir, main page]

AR035660A1 - Compuestos 3,10-dibromo-8-cloro-11h-benzo[5,6]ciclohepta[1,2-b]piridin-11-il-4-piperidinilos o sus sales farmaceuticamente aceptables, composiciones farmaceuticas que los comprenden, usos de los mismos para preparar medicamentos, y un procedimiento para producir un compuesto intermediario para produ - Google Patents

Compuestos 3,10-dibromo-8-cloro-11h-benzo[5,6]ciclohepta[1,2-b]piridin-11-il-4-piperidinilos o sus sales farmaceuticamente aceptables, composiciones farmaceuticas que los comprenden, usos de los mismos para preparar medicamentos, y un procedimiento para producir un compuesto intermediario para produ

Info

Publication number
AR035660A1
AR035660A1 ARP010105505A ARP010105505A AR035660A1 AR 035660 A1 AR035660 A1 AR 035660A1 AR P010105505 A ARP010105505 A AR P010105505A AR P010105505 A ARP010105505 A AR P010105505A AR 035660 A1 AR035660 A1 AR 035660A1
Authority
AR
Argentina
Prior art keywords
compounds
dibromo
benzo
chloro
produce
Prior art date
Application number
ARP010105505A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR035660A1 publication Critical patent/AR035660A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un compuesto 3,10-dibromo-8-cloro-11H-benzo[5,6]ciclohepta[1,2-b]piridin-11-il-4-piperidinilo que es seleccionado del grupo que consiste en las fórmulas (1) a (6). Estos compuestos son inhibidores de la Transferasa de Proteína Farnesilo. Se describen también composiciones farmacéuticas que comprenden dichos compuestos, los usos de los mismos para preparar un medicamento para tratar desordenes asociados con FPT, así como también un procedimiento para producir un compuesto intermediario de fórmula (7) 3,10-dibromo-8-cloro-11H-benzo[5,6]ciclohepta[1,2-b]piridin-11-il-4-piperidinilo metil sustituido para producir los compuestos.
ARP010105505A 2000-11-29 2001-11-27 Compuestos 3,10-dibromo-8-cloro-11h-benzo[5,6]ciclohepta[1,2-b]piridin-11-il-4-piperidinilos o sus sales farmaceuticamente aceptables, composiciones farmaceuticas que los comprenden, usos de los mismos para preparar medicamentos, y un procedimiento para producir un compuesto intermediario para produ AR035660A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25397100P 2000-11-29 2000-11-29

Publications (1)

Publication Number Publication Date
AR035660A1 true AR035660A1 (es) 2004-06-23

Family

ID=22962414

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105505A AR035660A1 (es) 2000-11-29 2001-11-27 Compuestos 3,10-dibromo-8-cloro-11h-benzo[5,6]ciclohepta[1,2-b]piridin-11-il-4-piperidinilos o sus sales farmaceuticamente aceptables, composiciones farmaceuticas que los comprenden, usos de los mismos para preparar medicamentos, y un procedimiento para producir un compuesto intermediario para produ

Country Status (20)

Country Link
US (1) US6528523B2 (es)
EP (1) EP1337522B1 (es)
JP (1) JP2004514717A (es)
KR (1) KR20030060939A (es)
CN (1) CN1198816C (es)
AR (1) AR035660A1 (es)
AT (1) ATE371655T1 (es)
AU (2) AU3514302A (es)
CA (1) CA2429720C (es)
DE (1) DE60130239T2 (es)
ES (1) ES2291368T3 (es)
HK (1) HK1054226A1 (es)
HU (1) HUP0302104A2 (es)
IL (1) IL155668A0 (es)
MX (1) MXPA03004878A (es)
NZ (1) NZ525572A (es)
PE (1) PE20020635A1 (es)
TW (1) TWI225058B (es)
WO (1) WO2002044164A1 (es)
ZA (1) ZA200303635B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2546727C (en) 2003-11-20 2012-10-02 Children's Hospital Medical Center Gtpase inhibitors and methods of use
JP2009508809A (ja) 2005-07-29 2009-03-05 チルドレンズ ホスピタル メディカル センター ＲＡＣ−１ＧＴＰａｓｅのＧＴＰａｓｅ阻害因子とその使用方法およびその結晶構造
WO2013166043A1 (en) 2012-05-02 2013-11-07 Children's Hospital Medical Center Rejuvenation of precursor cells
US10028503B2 (en) 2014-06-18 2018-07-24 Children's Hospital Medical Center Platelet storage methods and compositions for same
EP4013402B1 (en) 2019-08-16 2024-11-06 Children's Hospital Medical Center Cdc-42 inhibitors for use in the treatment of age-related depression, sarcopenia or frailty

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661152A (en) * 1993-10-15 1997-08-26 Schering Corporation Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
NZ275646A (en) * 1993-10-15 1998-02-26 Schering Corp Tricyclic sulphonamide derivatives and medicaments
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US6365588B1 (en) 1993-10-15 2002-04-02 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5684013A (en) 1995-03-24 1997-11-04 Schering Corporation Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5801175A (en) 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
WO1997023478A1 (en) * 1995-12-22 1997-07-03 Schering Corporation Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
US5874442A (en) * 1995-12-22 1999-02-23 Schering-Plough Corporation Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
US5784442A (en) 1996-02-02 1998-07-21 Telefonaktiebologet Lm Ericsson (Publ) System and method for real-time billing in a radio telecommunications network
US5925757A (en) * 1996-07-26 1999-07-20 Schering Corporation Method for preparing carboxamides
US5985879A (en) 1996-09-13 1999-11-16 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6040305A (en) 1996-09-13 2000-03-21 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6071907A (en) 1996-09-13 2000-06-06 Schering Corporation Tricyclic compounds useful as FPT inhibitors
US5861395A (en) 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
US5945429A (en) 1996-09-13 1999-08-31 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6030982A (en) 1996-09-13 2000-02-29 Schering Corporationm Compounds useful for inhibition of farnesyl protein transferase
US6239140B1 (en) 1997-06-17 2001-05-29 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5925639A (en) 1997-06-17 1999-07-20 Schering Corporation Keto amide derivatives useful as farnesyl protein transferase inhibitors
US6159984A (en) 1997-06-17 2000-12-12 Schering Corporation Farnesyl protein transferase inhibitors
CA2294347C (en) * 1997-06-17 2008-01-29 Schering Corporation Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
US5939416A (en) 1997-06-17 1999-08-17 Schering Corporation Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
US6228865B1 (en) 1997-06-17 2001-05-08 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6051582A (en) 1997-06-17 2000-04-18 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
HUP0004627A2 (hu) * 1997-06-17 2001-10-28 Schering Corp. Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények
US6358968B1 (en) 1997-06-17 2002-03-19 Schering Corporation N-substituted urea inhibitors of farnesyl-protein transferase
US6211193B1 (en) 1997-06-17 2001-04-03 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5852034A (en) 1997-06-17 1998-12-22 Schering Corporation Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
US6221322B1 (en) 1997-11-27 2001-04-24 Dowa Mining Co., Ltd Strontium nitrate and method for manufacturing same
US6096757A (en) 1998-12-21 2000-08-01 Schering Corporation Method for treating proliferative diseases
US6362188B1 (en) 1998-12-18 2002-03-26 Schering Corporation Farnesyl protein transferase inhibitors
US6372747B1 (en) 1998-12-18 2002-04-16 Schering Corporation Farnesyl protein transferase inhibitors
US6432959B1 (en) 1998-12-23 2002-08-13 Schering Corporation Inhibitors of farnesyl-protein transferase
US6410451B2 (en) 1999-09-27 2002-06-25 Lam Research Corporation Techniques for improving etching in a plasma processing chamber

Also Published As

Publication number Publication date
JP2004514717A (ja) 2004-05-20
US20020115679A1 (en) 2002-08-22
TWI225058B (en) 2004-12-11
DE60130239D1 (en) 2007-10-11
CN1198816C (zh) 2005-04-27
US6528523B2 (en) 2003-03-04
DE60130239T2 (de) 2008-05-21
EP1337522B1 (en) 2007-08-29
NZ525572A (en) 2004-11-26
CN1476444A (zh) 2004-02-18
HK1054226A1 (zh) 2003-11-21
EP1337522A1 (en) 2003-08-27
AU3514302A (en) 2002-06-11
CA2429720C (en) 2009-12-29
ATE371655T1 (de) 2007-09-15
WO2002044164A1 (en) 2002-06-06
HUP0302104A2 (hu) 2003-09-29
IL155668A0 (en) 2003-11-23
ES2291368T3 (es) 2008-03-01
AU2002235143B2 (en) 2006-03-02
PE20020635A1 (es) 2002-07-11
CA2429720A1 (en) 2002-06-06
MXPA03004878A (es) 2003-08-19
ZA200303635B (en) 2004-08-12
KR20030060939A (ko) 2003-07-16

Similar Documents

Publication Publication Date Title
MX2022000854A (es) Derivados de 2-morfolinopiridina sustituidos como inhibidores de la cinasa atr.
UY26968A1 (es) Agentes terapéuticos
AR035792A1 (es) Compuestos de n-(4-quinazolinil)-n-(1h-indazol-5-il) amina, inhibidor de la rho-quinasa, su uso para la fabricacion de un medicamento y metodo para prepararlo
AR041932A1 (es) Derivados de ciclohexano espirociclicos, preparacion de los mismos, su uso en la fabricacion de medicamentos y dichos medicamentos.
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
CY1106166T1 (el) Παραγωγα κουιναζολινης ως αναστολεις vegf.
AR037368A1 (es) Imidazolilpirrolotriazinas c-5 modificadas y composiciones farmaceuticas que las comprenden
UY26143A1 (es) Derivados heterocíclicos útiles como agentes anticancerosos
AR024060A1 (es) Nuevos compuestos farmaceuticamente activos
ES2160648T3 (es) Derivados de piridina.
AR058780A1 (es) Imidazopirazinas como inhibidores de quinasas dependientes de ciclina
MX9300786A (es) Compuestos hipolipidaemicos.
ES2158778B1 (es) Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen.
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
PA8495101A1 (es) Derivados de 13-metileritromicina
MX376743B (es) Síntesis de lactonas de ácido resorcílico útiles como agentes terapéuticos
ECSP034602A (es) Derivados sustituidos 2-fenilaminoimidazolina fenil cetona como antagonistas ip
BRPI0417520A (pt) 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon
MX9301240A (es) Derivados heterociclicos de cetona, condensados, metodo para su produccion y composicion farmaceutica que los contiene.
MX2018013325A (es) Derivados de adenina como inhibidores de proteína quinasa.
PT1165544E (pt) 1,4-di-hidroindeno¬1,2-c|pirazoles substituidos como inibidores de tirosina-quinase
ES2033062T3 (es) Un procedimiento de preparacion de derivados n-imidazolil y n-imidazolilmetil.
BR0214695A (pt) Derivados de pirazol com anel fundido
ECSP066349A (es) Inhibidores de transferasa de proteína de farnesilo novedosos como agentes antitumorales